Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson’s disease treatment

Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson’s disease treatment

10.1371/journal.pone.0188212

Saved in:

Bibliographic Details
Main Authors:	Shao Y.-M., Ma X., Paira P., Tan A., Herr D.R., Lim K.L., Ng C.H., Venkatesan G., Klotz K.-N., Federico S., Spalluto G., Cheong S.L., Chen Y.Z., Pastorin G.
Other Authors:	PHARMACY
Format:	Article
Published:	Public Library of Science 2018
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/150087
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Discovery of simplified N2-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: Efficient synthetic approaches, biological evaluations and molecular docking studies
by: Venkatesan, G., et al.
Published: (2014)

A facile and novel synthesis of N2-, C6-substituted pyrazolo[3,4- d ]pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists
by: Venkatesan G., et al.
Published: (2016)

Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo- pyrimidines as potent human A3 adenosine receptor antagonists
by: Cheong, S.L., et al.
Published: (2014)

DISCOVERY OF INDOLYL PIPERAZINYLPYRIMIDINES WITH DUAL-TARGET PROFILES ADENOSINE A2¿ AND DOPAMINE D2 RECEPTORS FOR PD TREATMENT
by: SHAO YI-MING
Published: (2015)

The A3 adenosine receptor as multifaceted therapeutic target: Pharmacology, medicinal chemistry, and in silico approaches
by: Cheong, S.L., et al.
Published: (2014)

Organoruthenium antagonists of human A3 adenosine receptors
by: Paira, P., et al.
Published: (2014)

Exploring the directionality of 5-substitutions in a new series of 5-alkylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine as a strategy to design novel human A3 adenosine receptor antagonists
by: Federico, S., et al.
Published: (2014)

Synthesis and biological evaluation of a new series of 1, 2, 4-triazolo[1, 5-α]-1, 3, 5-triazines as human a 2a adenosine receptor antagonists with improved water solubility
by: Federico, S., et al.
Published: (2014)

The significance of 2-furyl ring substitution with a 2-(para -substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA3 adenosine receptors antagonists: New insights into structure-affinity relationship and receptor-antagonist recognition
by: Cheong, S.L., et al.
Published: (2014)

Does the combination of optimal substitutions at the C 2-, N 5- and N 8-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A 3 adenosine receptors?
by: Cheong, S.L., et al.
Published: (2014)

Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A2A and A3 receptor pyrazolo-triazolo-pyrimidine antagonists binding sites
by: Michielan, L., et al.
Published: (2014)

Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process
by: Pastorin, G., et al.
Published: (2014)

The study of dopamine metabolism with LRRK2 variants in Parkinson’s disease
by: Kwok, Wei Hao
Published: (2015)

Dysregulation of dopamine metabolism in LRRK2-associated Parkinson's disease.
by: Chan, Clarice Zi Ying.
Published: (2013)

Dopamine D2 receptor taqIA and TaqIB polymorphisms in Parkinson's disease
by: Tan E.-K., et al.
Published: (2018)

Choosing dopamine agonists in Parkinson's disease
by: Tan E.-K., et al.
Published: (2018)

Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease
by: Tan, E.K., et al.
Published: (2014)

Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease
by: Goggi, J.L., et al.
Published: (2021)

Dopamine agonists and their role in Parkinson's disease treatment
by: Tan E.-K.
Published: (2018)

Peripheral edema and dopamine agonists in Parkinson disease [5]
by: Tan E.-K.
Published: (2018)

Dopamine (DA) toxicity in pathogenesis and therapy of Parkinson’s disease (PD)
by: Zhou, Zhidong, et al.
Published: (2022)

The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis
by: Zhou, Zhi Dong, et al.
Published: (2023)

Non-mammalian animal models of Parkinson's disease for drug discovery
by: Lim, K.-L.
Published: (2014)

DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism-Dystonia
by: Joanne Ng, et al.
Published: (2020)

The Therapeutic Implications of Tea Polyphenols against Dopamine (DA) Neuron Degeneration in Parkinson's Disease (PD)
by: Zhou, Zhidong, et al.
Published: (2022)

Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: An open-label study
by: Kim J.-M., et al.
Published: (2018)

Design, synthesis and evaluation of new indolylpyrimidylpiperazines for gastrointestinal cancer therapy
by: Tan, A., et al.
Published: (2021)

Dopamine (DA) Dependent Toxicity Relevant to DA Neuron Degeneration in Parkinson’s Disease (PD)
by: Zhou, Zhidong, et al.
Published: (2022)

2′-O methylation of internal adenosine by flavivirus NS5 methyltransferase
by: Dong, H., et al.
Published: (2016)

A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
by: Tay, Apple Hui Min, et al.
Published: (2023)

Dysregulated dopamine metabolism in LRRK2 mutants
by: Chia, Xin Tian
Published: (2015)

PLA2G6 mutations and Parkinson's disease
by: Tan, E.K., et al.
Published: (2014)

CHCHD2 and Parkinson's disease
by: Foo J.N., et al.
Published: (2018)

The role of adenosine, adenosine receptors and transporters in the modulation of cell death
by: SUN WENTIAN
Published: (2010)

Dopamine-induced reduction and functionalization of graphene oxide nanosheets
by: Xu, L.Q., et al.
Published: (2014)

Concentrative transport of adenosine in murine splenocytes: Limitation by an ecto-adenosine deaminase
by: Lee, C.-W., et al.
Published: (2014)

A multimode responsive aptasensor for adenosine detection
by: Zhao, N, et al.
Published: (2020)

Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
by: Haugarvoll K., et al.
Published: (2018)

Lingo2 variants associated with essential tremor and Parkinson's disease
by: Wu Y.-W., et al.
Published: (2018)

Analysis of LRRK2 functional domains in nondominant Parkinson disease
by: Skipper L., et al.
Published: (2018)